Bio-Rad Laboratories Class A
498 hedge funds and large institutions have $9.18B invested in Bio-Rad Laboratories Class A in 2022 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 159 increasing their positions, 200 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
498
Holders Change
-14
Holders Change %
-2.73%
% of All Funds
8.42%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.14%
New
65
Increased
159
Reduced
200
Closed
70
Calls
$41.9M
Puts
$115M
Net Calls
-$72.7M
Net Calls Change
-$39.1M
Top Buyers
| 1 |
VAM
Veritas Asset Management
London,
United Kingdom
|
+$380M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$70.7M |
| 3 |
AIM
Artemis Investment Management
Edinburgh,
United Kingdom
|
+$47.9M |
| 4 |
Millennium Management
New York
|
+$44.3M |
| 5 |
NC
Nitorum Capital
New York
|
+$38.6M |
Top Sellers
| 1 |
Marshall Wace
London,
United Kingdom
|
-$120M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$112M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$108M |
| 4 |
BlackRock
New York
|
-$83.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$41.6M |
